HDAC9 and cancer: HDAC inhibition has been shown to induce cell cycle arrest, tumor angiogenesis inhibition, differentiation of some transformed cell lines, and/or apoptosis in tumor cells, indicating its potential as a therapeutic target for cancer treatment (27).